A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disorders
Abstract Background Mass spectrometry-based quantitative proteomics has a demonstrated utility in increasing the diagnostic yield of mitochondrial disorders (MDs) and other rare diseases. However, for this technology to be widely adopted in routine clinical practice, it is crucial to accurately esti...
Saved in:
| Main Authors: | Francisco Santos Gonzalez, Daniella H. Hock, David R. Thorburn, Dylan Mordaunt, Nicholas A. Williamson, Ching-Seng Ang, David A. Stroud, John Christodoulou, Ilias Goranitis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Orphanet Journal of Rare Diseases |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13023-024-03462-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review: Utility of mass spectrometry in rare disease research and diagnosis
by: Teresa Zhao, et al.
Published: (2025-03-01) -
Untargeted proteomics enables ultra-rapid variant prioritisation in mitochondrial and other rare diseases
by: Daniella H. Hock, et al.
Published: (2025-05-01) -
Mitochondrial proteomics of the acetic acid – induced programmed cell death response in a highly tolerant Zygosaccharomyces bailii – derived hybrid strain
by: Joana F Guerreiro, et al.
Published: (2016-01-01) -
Mitochondrial transplantation normalizes transcriptomic and proteomic shift associated with ischemia reperfusion injury in neonatal hearts donated after circulatory death
by: Ilias P. Doulamis, et al.
Published: (2024-12-01) -
MITOCHONDRIAL PROTEIN PROFILE AND ITS ROLE IN PATHOLOGIC PROCESSES
by: Ye. A. Kosterina, et al.
Published: (2013-06-01)